Procalcitonin for patient stratification and identification of bacterial co-infection in COVID-19
Jennie Han, Timothy Gatheral, Craig Williams
Abstract
Editor – an abundance of biomarkers has been measured in hospitalised patients with COVID-19. Initial reports from China have shown that most patients with COVID-19 did not have elevated procalcitonin (>0.5 μg/L).[1,2][1] However, elevated levels were found more frequently in severe cases and in
Topics & Concepts
ProcalcitoninMedicineCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakRisk stratificationPneumoniaInternal medicineStratification (seeds)Intensive care medicinePathologySepsisInfectious disease (medical specialty)DiseaseBotanySeed dormancyOutbreakGerminationDormancyBiologySepsis Diagnosis and TreatmentCOVID-19 Clinical Research StudiesThermal Regulation in Medicine